Cargando…
Clinically relevant mitochondrial-targeted therapy improves chronic outcomes after traumatic brain injury
Pioglitazone, an FDA-approved compound, has been shown to target the novel mitochondrial protein mitoNEET and produce short-term neuroprotection and functional benefits following traumatic brain injury. To expand on these findings, we now investigate the dose- and time-dependent effects of pioglitaz...
Autores principales: | Hubbard, W Brad, Spry, Malinda L, Gooch, Jennifer L, Cloud, Amber L, Vekaria, Hemendra J, Burden, Shawn, Powell, David K, Berkowitz, Bruce A, Geldenhuys, Werner J, Harris, Neil G, Sullivan, Patrick G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719838/ https://www.ncbi.nlm.nih.gov/pubmed/34972207 http://dx.doi.org/10.1093/brain/awab341 |
Ejemplares similares
-
Temporal changes in inflammatory mitochondria-enriched microRNAs following traumatic brain injury and effects of miR-146a nanoparticle delivery
por: Wang, Wang-Xia, et al.
Publicado: (2020) -
Pioglitazone restores mitochondrial function but does not spare cortical tissue following mild brain contusion
por: Hubbard, W Brad, et al.
Publicado: (2023) -
Characterizing Sex Differences in Mitochondrial Dysfunction After Severe Traumatic Brain Injury in Mice
por: Kalimon, Olivia J., et al.
Publicado: (2023) -
LRP1 Deficiency Promotes Mitostasis in Response to Oxidative Stress: Implications for Mitochondrial Targeting after Traumatic Brain Injury
por: Velmurugan, Gopal V., et al.
Publicado: (2023) -
Mitochondrial Dysfunction After Repeated Mild Blast Traumatic Brain Injury Is Attenuated by a Mild Mitochondrial Uncoupling Prodrug
por: Hubbard, W. Brad, et al.
Publicado: (2023)